Suppliers / Pharmacia & UpJohn

Pharmacia & UpJohn

United States 7 duplicate records merged Updated 9 July 2026

Pharmacia & UpJohn is an API manufacturer based in United States. It appears in 80 regulatory filings across 7 regulators, without an active US DMF or CEP on file. Its filings concentrate with Health Canada, US FDA and ARCSA (EC). Its GMP standing is certified by ANVISA (Brazil), EAEU_EEC and US FDA. Its most recent recorded inspection, by US FDA, closed on 16 June 2023 as VAI.

0
active US DMFs
0
valid CEPs
4
registered plants 1 with an FDA FEI number
80
filings across 7 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
8 of 8 confirmed
EU GMP
0 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 16 June 2023 VAI US FDA
  • 20 May 2021 VAI US FDA
  • 21 September 2018 VAI US FDA
  • 7 November 2017 VAI US FDA
  • 12 November 2015 VAI US FDA
  • 9 July 2015 VAI US FDA
  • 28 February 2014 VAI US FDA
  • 20 June 2013 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Kalamazoo, United Arab Emirates Not on file
Kalamazoo, United Arab Emirates Not on file
KALAMAZOO, United States Not on file
Kalamazoo, United States 1810189

What they file, and where

Molecule Regulators Docs
Hydrocortisone SFDA (Saudi Arabia) 1
Linezolid SFDA (Saudi Arabia) 1
Neomycin SFDA (Saudi Arabia) 1
Progesterone SFDA (Saudi Arabia) 1
Triamcinolone Acetonide SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
Health Canada 33 None
US FDA 30 1
ARCSA (EC) 6 None
MINSA (CR) 6 None
DMP (NO) 3 None
SFDA (Saudi Arabia) 1 None
ANVISA (Brazil) None 4
EAEU_EEC None 2

Comparing suppliers?

Choose your molecules and target markets. Pharmacia & UpJohn comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 16 June 2023.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates